Henry Tarlian, MD
Vascular Surgery · Mesa, AZNPI 1346215589
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,065 of the $6,136 with a category attached, or 82.6%. 29 manufacturers reported payments, led by Endologix LLC at 30.8% of the total. That places this record below the midpoint for vascular surgery clinicians in AZ, where the typical reported total is $6,983.
Across 149 payments — averaging $41.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$2K
- Terumo Medical Corporation$870
- W. L. Gore & Associates, Inc.$856
- Philips North America LLC$616
- Johnson & Johnson$431
- Cook Medical LLC$184
- plus $1K from 23 others
What the payments were for
- Consulting fees$4007%
- Travel & lodging$67111%
- Food & beverage$5,06583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 10 | $1,892 |
| Terumo Medical Corporation | 7 | $870 |
| W. L. Gore & Associates, Inc. | 20 | $856 |
| Philips North America LLC | 12 | $616 |
| Johnson & Johnson(2 entities) | 30 | $431 |
| Cook Medical LLC | 10 | $184 |
| Biotronik Inc. | 2 | $181 |
| Medtronic(2 entities) | 7 | $168 |
| E.r. Squibb & Sons, L.L.C. | 12 | $166 |
| Silk Road Medical, Inc. | 7 | $131 |
| Bard Peripheral Vascular, Inc. | 2 | $121 |
| Bolton Medical Inc | 1 | $70 |
| Cardiovascular Systems Inc. | 4 | $66 |
| Pfizer | 4 | $60 |
| Boston Scientific | 4 | $54 |
| Biocompatibles, Inc. | 3 | $37 |
| Angiodynamics, Inc. | 1 | $30 |
| Biom'up France SAS | 2 | $28 |
| Veryan Medical Incorporated | 1 | $25 |
| Inari Medical, Inc. | 1 | $18 |
| Mimedx Group, Inc. | 1 | $18 |
| Reflow Medical Inc | 1 | $18 |
| Misonix Inc | 1 | $17 |
| Getinge USA Sales, LLC | 1 | $16 |
| Balt USA, LLC | 1 | $14 |
| Biom'up SA | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $11 |
| Artivion, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Torus Stent Graft System$818
- ENDOCROSS Device$818
- Alto Abdominal Stent Graft System$558
- AFX2 Bifurcated Endograft System$509
- Navicross$406
- AZUR$406
- GlideWire$406
- (6554) Peripheral Vascular Undivided$400
- GLIDESHEATH SLENDER$390
- EXCLUDER AAA Endoprosthesis$200
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$162
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$133
- RotarexS 6 F x 135 cm$102
How this compares
$6,136 in reported general payments places this provider in the 45th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 180 | $137,418 |
| EliquisApixaban | 101 | $80,758 |
| ClopidogrelClopidogrel Bisulfate | 590 | $4,928 |
| Cilostazol | 129 | $2,545 |
| Enoxaparin Sodium | 47 | $1,724 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $477 |
| Atorvastatin Calcium | 40 | $340 |
| Rosuvastatin Calcium | 15 | $215 |
| Doxycycline Hyclate | 14 | $102 |
| Amlodipine Besylate | 21 | $60 |
| Gabapentin | 12 | $57 |
| Prednisone | 19 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $431 | $137,418180 claims |
| PfizerEliquis | $60 | $80,758101 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Mesa
- Hammad AmerMesa$169K
- Xiaoyi LiMesa$16K
- Daniel KrcelicMesa$10K
- David PaoliniMesa$9K
- Stacey HancockMesa$7K
- Paul RiesenmanMesa$5K
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Baljeet UppalSun City$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.